ABP

Abpro Holdings
ABP

5.88 USD
+0.61
11.57%
At close Updated Nov 4, 9:44 AM EST
1 day
11.57%
5 days
-2%
1 month
-0.68%
3 months
-17.99%
6 months
-14.41%
Year to date
-87.52%
1 year
-98.29%
5 years
-98.02%
10 years
-98.02%
 

About: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Employees: 6

Healthcare Biotechnology
0
Funds holding %
of 7,506 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™